Skip to main content
Webinar banner
Transplant Considerations for the ACHD Patient #ACHACares
Were you born with a congenital heart defect and told you might need a heart transplant one day? Have you already had a heart transplant? If you answered yes to either of these questions, you don’t want to miss this webinar. Advanced therapy options, including transplant and mechanical circulatory support that exist for ACHD patients, will be discussed. You will also learn when patients should be referred, what to expect from an evaluation standpoint, and risks/benefits to these therapies. The most recent research and data will be presented. In addition, areas where the field is lacking, as well as options for new studies will be presented.

Feb 13, 2019 7:00 PM in Eastern Time (US and Canada)

* Required information


Jonathan Menachem, MD
Director of Advanced Congenital Cardiac Therapies (ACCT) @Vanderbilt University
Jonathan Menachem is a transplant cardiologist and director of Advanced Congenital Cardiac Therapies (ACCT) at Vanderbilt University. Dr. Menachem attended Tulane University School of Medicine and then completed his internal medicine residency at Duke University. Subsequently, he completed his cardiology (including a dedicated ACHD year) and advanced heart failure fellowships at the Hospital of the University of Pennsylvania. The majority of Dr. Menachem’s research is focused on advanced therapies including transplant and mechanical circulatory support for ACHD patients.